Novo and Sanofi Ventures both participated in a series A round for the neurodegenrative disease drug developer, which is led by EIRs at Novo Seeds.

The musculoskeletal healthcare provider has added cash from Intermountain Healthcare, Ascension Ventures and Echo Health Ventures to a round now surpassing $50m.

The M12-backed workforce management software developer has increased its overall funding to $115m through a series C round led by SoftBank.

Clal Insurance and Menora Mivtachim have become the latest corporate investors in Silk, which is also backed by Western Digital and Mitsui.

The Endeavor-backed cosmetics brand raised its latest funding at a $1.8bn valuation, increasing its overall funding to $266m.

The cybersecurity technology provider, backed by LG, Samsung, HP and Nvidia, added cash from Chrysalis Investments to a series D round now totalling $167m.

The FinAdvantage-backed gaming platform developer has now raised $90m in total, Hike having exited the company earlier this year.

GV helped geometric search technology developer Physna raise $56m while multiple corporates took part in a round nearly doubling study app developer Mathpresso's total funding to $105m.

Novo-backed Procept BioRobotics has secured series G funding to further commercialise its surgical robotic system.

Lilly Asia Ventures is among the participants in a series A round for the lung cancer drug developer that could potentially reach $150m.